Europe's Eureka research programme will invest €33 million to fund 25 new collaborative R&D projects. The agreement was announced at a meeting in Eilat, under Israel's chairmanship of Eureka.
CellCentric, a biotechnology company specialising in epigenetics, is to sponsor a collaboration in cancer research at the Wolfson Institute of Biomedical Research, University College London.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.